ORCHARD THERAPEUTICS PLC.

In News

Orchard Therapeutics Awarded Innovation Passport Designation for OTL-201 in MPS-IIIA - Yahoo Finance

Yahoo Finance - Apr 30, 2026

Kyowa Kirin acquires Orchard Therapeutics for $477.6m - Pharmaceutical Technology

Pharmaceutical Technology - Jan 25, 2024

GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics - GSK

GSK - Apr 12, 2018

Orchard sets out to sell world’s priciest gene therapy - biopharmadive.com

biopharmadive.com - Mar 20, 2024

Orchard-Kyowa scores US approval for gene therapy Lenmeldy - bioworld.com

bioworld.com - Mar 18, 2024

Orchard (ORTX) Up 97% on $478M Acquisition Deal With Kyowa Kirin - Yahoo Finance

Yahoo Finance - Oct 06, 2023

£438 million investment for UCL gene therapy spinouts | UCL News - UCL – University College London - UCL | University College London

UCL | University College London - Nov 08, 2018

Orchard turns to layoffs in cutting gene therapy research - biopharmadive.com

biopharmadive.com - Mar 30, 2022

Orchard Therapeutics plc (NASDAQ: ORTX) - Share Price - intelligentinvestor.com.au

intelligentinvestor.com.au - Dec 28, 2024

Tiny U.K. Biotech Takes On Glaxo’s $730,000 Gene Therapy - Bloomberg.com

Bloomberg.com - Mar 06, 2018

Tangled tale: Research, profits and the ‘bubble baby’ syndrome - Capitol Weekly

Capitol Weekly - May 11, 2021

This East Bay site was supposed to help lead a biomanufacturing revolution. Now the company is pulling back - The Business Journals

The Business Journals - Jun 10, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment